In‐depth molecular analysis of combined and co‐primary pulmonary large cell neuroendocrine carcinoma and adenocarcinoma

Up to 14% of large cell neuroendocrine carcinomas (LCNECs) are diagnosed in continuity with nonsmall cell lung carcinoma. In addition to these combined lesions, 1% to 7% of lung tumors present as co‐primary tumors with multiple synchronous lesions. We evaluated molecular and clinicopathological char...

Descripción completa

Detalles Bibliográficos
Autores principales: Hermans, Bregtje C. M., Derks, Jules L., Hillen, Lisa M., van der Baan, Irene, van den Broek, Esther C., von der Thüsen, Jan H., van Suylen, Robert‐Jan, Atmodimedjo, Peggy N., den Toom, T. Dorine, Coumans‐Stallinga, Cecile, Timens, Wim, Dinjens, Winand N. M., Dubbink, Hendrikus J., Speel, Ernst‐Jan M., Dingemans, Anne‐Marie C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Cancer Genetics and Epigenetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298697/
https://www.ncbi.nlm.nih.gov/pubmed/34674268
http://dx.doi.org/10.1002/ijc.33853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298697/
https://www.ncbi.nlm.nih.gov/pubmed/34674268
http://dx.doi.org/10.1002/ijc.33853

Ejemplares similares